Reporte de un caso clínico Sindrome de Rendu – Osler – Weber y Sîndrome Antifosfolipido
(Report of a clinical case Rendu – Osler – Weber Syndrome and Antiphospholipid Syndrome)
DOI:
https://doi.org/10.53358/lauinvestiga.v10i2.896Keywords:
Síndrome De Rendu – Osler – Weber, Síndrome Antifosfolípido, malformaciones arterio – venosas, telangiectasia hemorrágica hereditariaAbstract
Rendu-Osler-Weber syndrome (HHT) is a vascular disorder characterized by the presence of telangiectasias and arteriovenous malformations. It is an autosomal dominant multisystem dysplastic vascular disorder. Antiphospholipid antibody syndrome is an autoimmune disease characterized by the formation of abnormal proteins in the blood called antiphospholipid autoantibodies (APs), which cause clots to form in the arteries and veins. Acute pulmonary embolism in a patient with arteriovenous malformation is a predisposing factor for potential complications. There are few case reports in which these two conditions were found at the same time, it is associated with an increased thrombotic risk due to iron deficiency. The clinical case of a 21-year-old patient with a history of HHT and findings of alveolar hemorrhage is presented, for which an immunological pathology is studied, finding positive results for APS.
Downloads
References
Bustamante F, Tenreiro Picón O, Tenreiro A, Bustamante E. Síndrome de Rendu- Osler-Weber: presentación de un caso clínico. Revista de la Universidad de los Andes. 2016 marzo; 5(2).
Di Consola , Cazzolla A, Scivetti , Testa N, Lo Muzio L, Favia G. Síndrome de Rendu-Osler-Weber o Telangiectasia Hemorrágica Hereditaria (HHT): Descripción de dos casos y revisión de la literatura. Avances de Odontoestomatología. 2005 mayo ; 21 (6).
Guglielmetti , Rodriguez , Conlledo. Síndrome de Rendu-Osler-Weber en Paciente Adulto: Reporte de un Caso y Revisión de la Literatura. Revista Chilena Dermatológica. 2010; 26(3).
Cruz - Contreras D. Síndrome de anticuerpos antifosfolipídicos; patogénesis, diagnóstico y tratamiento. Revista de Hematología. 2016 octubre; 17(4).
Sobrino Grande C, Villalobos Sánchez L, Valero Expósito M. Síndrome antifosfolípido. Enfermedades del Sistema inmune y Reumatológicas. 2017; 12(27).
Brenner B, Blumenfeld Z, Markiewicz W, Reisner SA. Cardiac involvement in patients with primary antiphospholipid syndrome. J Am Coll Cardiol 1991; 18: 931-6.
Marcos Rodríguez P. J., Montero Martínez C., Verea Hernando H.. Hemorragia pulmonar y síndrome antifosfolípido primario: aportación de un caso y revisión de la literatura. An. Med. Interna (Madrid) [Internet]. 2007 Mar [citado 2023 Mayo 08] ; 24( 3 ): 125-128. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-71992007000300005&lng=es.
Deane KD, West SG. Antiphospholipid antibodies as a cause of pulmonary capillaritis and diffuse alveolar hemorrhage: a case series and literature review. Semin Arthritis Rheum 2005; 35: 154-65.
Espinosa G, Cervera R, Font J, Asherson RA. The lung in the antiphospholipid syndrome. Ann Rheum Dis 2002;61:195-198.
Crausman RS, Achenbach GA, Pluss WT, O'Brien RF, Jennings CA. Pulmonary capillaritis and alveolar hemorrhage associated with the antiphospholipid antibody syndrome. J Rheumatol 1995; 22: 554-6.
Gertner E, Lie JT. Pulmonary capillaritis, alveolar hemorrhage, and recurrent microvascular thrombosis in primary antiphospholipid syndrome. J Rheumatol 1993; 20: 1224-8.
Gertner E. Diffuse alveolar hemorrhage in the antiphospholipid syndrome: spectrum of disease and treatment. J Rheumatol 1999; 26: 805-7.
Eleni Xourgia;Maria G. Tektonidou. An Update on Antiphospholipid Syndrome. 2022(6)
Garcia D, Erkan D.Antiphospholipid Syndrome: Diagnosis and Management.2022
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Francisco Rafael Pinto Pineda, Verónica Alejandra Pinto Pineda, Karolin Paulina Lalama Gómez
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The authors retain the copyright and guarantee the journal the right to be the first publication of the work as well as licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License that allows others to share the work with an acknowledgment of the authorship of the work and the initial publication in this magazine. Authors may separately establish additional agreements for the non-exclusive distribution of the version of the work published in the journal (for example, placing it in an institutional repository or publishing it in a book), with an acknowledgment of its initial publication in this journal.
La U Investiga by La U Investiga is licensed under a Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional License.You can find permissions beyond those granted with this license athttp://revistasojs.utn.edu.ec/index.php/lauinvestiga/index
